SCHEMBL30459676

SCHEMBL30459676

O=C1c2c(F)cc(CO)cc2CN1C1CCCNC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 5/20 0.50
▸ HTR2B P41595 10/20 0.43
▸ HTR2C P28335 9/20 0.43
▸ HTR2A P28223 6/20 0.43
▸ HTR3E A5X5Y0 1/20 0.35
▸ HTR3B O95264 1/20 0.35
▸ HTR3A P46098 1/20 0.35
▸ TMEM97 Q5BJF2 1/20 0.35
▸ HTR3D Q70Z44 1/20 0.35
▸ HTR3C Q8WXA8 1/20 0.35
▸ POLB P06746 3/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30496975 0.89 PARP1 (0.50) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30004312 0.83 PARP1 (0.41) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL27093617 0.83 PARP1 (0.41) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30351817 0.80 PARP1 (0.47) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30460068 0.79 HTR2B (0.49) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30351699 0.79 PARP1 (0.47) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30695894 0.77 HTR2C (0.49) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL25228753 0.77 HTR2A (0.33) PARP1HTR2BHTR2CHTR2APOLB
SCHEMBL30352021 0.76 PARP1 (0.44) PARP1HTR2BHTR2CHTR2AHTR3E
SCHEMBL30352272 0.76 PARP1 (0.44) PARP1HTR2BHTR2CHTR2AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback